Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-06-21

FDA Approved: PYRIMETHAMINE — Supplemental Application (OAKRUM PHARMA, LLC)

View source ↗

Summary

FDA approved a supplemental NDA for Pyrimethamine submitted by Oakrum Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pyrimethamine (Pyrimethamine)

Snippet

SUPPL AP for PYRIMETHAMINE (PYRIMETHAMINE)